Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 19,142 shares at $2.93 ($56,086)
  9. 4 Open-market sale Director sold 4,720 shares at $2.97 ($14,018)
  10. 4 Open-market sale President and CEO sold 450,000 shares at $2.87 ($1,291,500)
  11. 4 Exercise or conversion Director acquired 24,720 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 61,800 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 24,720 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Sr Director Finance/Controller sold 6,000 shares at $2.23 ($13,380)
  19. 4 Exercise or conversion President and CEO acquired 15,450 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 6 of 36 · 720 filings